Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep 15:156:107565.
doi: 10.1016/j.neuropharm.2019.03.008. Epub 2019 Mar 4.

Violent offending in borderline personality disorder and attention deficit/hyperactivity disorder

Affiliations
Review

Violent offending in borderline personality disorder and attention deficit/hyperactivity disorder

Alexandra Sebastian et al. Neuropharmacology. .

Abstract

The prevalence of borderline personality disorder (BPD) and attention deficit/hyperactivity disorder (ADHD) is significantly higher among offenders compared to the prevalence found in the general population. Both disorders share important diagnostic characteristics and thus it has been suggested that they might follow a common developmental pathway. In this narrative review, we first discuss the potential links of disorder inherent symptoms such as impulsivity and emotion regulation difficulties and how they might elevate the risk of violent delinquency. We continue with highlighting that comorbidities particularly from the antisocial spectrum as well as comorbid substance use disorders need to be considered in the context of offending in individuals with BPD and ADHD. Finally, we summarize current therapeutic approaches for offenders with BPD and ADHD and associated challenges especially concerning the provision of treatment in prison settings. This article is part of the Special Issue entitled 'Current status of the neurobiology of aggression and impulsivity'.

Keywords: Aggression; Antisocial personality disorder; Emotion regulation; Impulsivity; Response inhibition; Substance use disorder.

PubMed Disclaimer

MeSH terms